D. Mehrotra, H. Janes, T. Fleming, P. Annunziato, K. Neuzil, L. Carpp, D. Benkeser, Elizabeth R. Brown, M. Carone, I. Cho, D. Donnell, M. Fay, Y. Fong, Shu Han, I. Hirsch, Ying Huang, Yunda Huang, O. Hyrien, M. Juraska, A. Luedtke, M. Nason, A. Vandebosch, Honghong Zhou, Myron S. Cohen, L. Corey, J. Hartzel, D. Follmann, P. Gilbert
Annals of Internal Medicine, 2020
Safe and effective vaccines are a critical component in the control of COVID-19. A group of industry, government, and academic researchers discuss pragmatic issues in the choice and interpretation of clinical endpoints for evaluating efficacy in COVID-19 vaccine trials.
Cited by 28 publications.
Field of study: Medicine